BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36318405)

  • 1. Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction.
    Rasul HO; Aziz BK; Ghafour DD; Kivrak A
    Mol Divers; 2023 Oct; 27(5):2273-2296. PubMed ID: 36318405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approach.
    Rasul HO; Aziz BK; Ghafour DD; Kivrak A
    Mol Divers; 2023 Jun; 27(3):1141-1162. PubMed ID: 35737256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer.
    Rasul HO; Aziz BK; Ghafour DD; Kivrak A
    J Mol Model; 2021 Dec; 28(1):17. PubMed ID: 34962586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and isolation of antimicrobial compounds from the flower extract of Hibiscus rosa-sinensis L: In silico and in vitro approaches.
    Vijayakumar S; Morvin Yabesh JE; Arulmozhi P; Praseetha PK
    Microb Pathog; 2018 Oct; 123():527-535. PubMed ID: 30086346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant-Based Bioactive Phthalates Derived from
    Yasmin F; Nazli ZI; Shafiq N; Aslam M; Bin Jardan YA; Nafidi HA; Bourhia M
    ACS Omega; 2023 Sep; 8(36):32677-32689. PubMed ID: 37720793
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of Hibiscus rosa-sinensis flower extract against human pathogens.
    Ruban P; Gajalakshmi K
    Asian Pac J Trop Biomed; 2012 May; 2(5):399-403. PubMed ID: 23569938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benchmarked molecular docking integrated molecular dynamics stability analysis for prediction of SARS-CoV-2 papain-like protease inhibition by olive secoiridoids.
    Thangavel N; Albratty M
    J King Saud Univ Sci; 2023 Jan; 35(1):102402. PubMed ID: 36338939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
    Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
    Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of natural diterpenes isolated from Azorella species targeting dispersin B using in silico approaches.
    Rasul HO; Sabir DK; Aziz BK; Guillermo Salgado M; Mendoza-Huizar LH; Belhassan A; Candia LG; Villada WC; Thomas NV; Ghafour DD
    J Mol Model; 2023 May; 29(6):182. PubMed ID: 37209272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of Hibiscus rosa-sinensis L. red flower against antibiotic-resistant strains of Helicobacter pylori and identification of the flower constituents.
    Ngan LTM; Tan MT; Hoang NVM; Thanh DT; Linh NTT; Hoa TTH; Nuong NTM; Hieu TT
    Braz J Med Biol Res; 2021; 54(7):e10889. PubMed ID: 34008759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
    Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
    J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An In silico Approach to Identify High Affinity Small Molecule Targeting m-TOR Inhibitors for the Clinical Treatment of Breast Cancer.
    Patidar K; Panwar U; Vuree S; Sweta J; Sandhu MK; Nayarisseri A; Singh SK
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1229-1241. PubMed ID: 31030499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring novel and potent molecules for disrupting DEPTOR-mTOR interaction through structure-steered screening, extra-exactitude molecular docking, prime binding free energy estimation and voguish molecular dynamics.
    Shah BA; Ganai SA; Koul AM; Mohan S; Amin A; Wani Z; Majeed U; Rajamanikandan S; Farooq F; Malik FA; Shah NN; Qadri RA
    J Biomol Struct Dyn; 2022; 40(22):12037-12047. PubMed ID: 34431457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Color, Antioxidant Capacity and Flavonoid Composition in
    Mejía JJ; Sierra LJ; Ceballos JG; Martínez JR; Stashenko EE
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838766
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative molecular dynamic simulation study on potent ligands targeting mTOR/FRB domain for breast cancer therapy.
    Sharma V; Panwar A; Sharma A; Punj V; Saini RV; Saini AK; Sharma AK
    Biotechnol Appl Biochem; 2022 Aug; 69(4):1339-1347. PubMed ID: 34056758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.